It will be important for clinicians to understand how ICI-mediated systemic T-cell activation impacts CD4-monocyte interactions within plaque, whether foam cells in particular retain some degree of monocyte antigen-presenting capabilities, and how T cells may play a reciprocal role in ASCVD-related monocyte function. This evidence concerns the gene CD4 and atherosclerosis.